Glaukos (NYSE:GKOS) PT Raised to $105.00

Glaukos (NYSE:GKOS – Free Report) had its price objective increased by Piper Sandler from $90.00 to $105.00 in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has an overweight rating on the medical instruments supplier’s stock. Other equities research analysts also recently issued research reports about the stock. Stifel […]

Related Keywords

Piper Sandler ,Alexr Thurman ,Marc Stapley ,Stifel Nicolaus ,Wells Fargo Company ,Glaukos Company Profile ,Needham Company ,Driehaus Capital Management ,Invesco Ltd ,Glaukos Corporation ,Norges Bank ,Free Report ,Wells Fargo ,Moderate Buy ,Get Free Report ,Director Marc Stapley ,Capital Management ,Glaukos Daily ,Glaukos ,Nyse Gkos ,Gkos ,Medical ,Boost Price Target ,